| Application no. and date | 19169275.5 (espacenet) (Federated) (European Patent Register), 20130604 | | Patent/reg. no. and date | DK/EP 3533792, 20210505 | | Publication date | 20190904 | | Priority no. and date | US 201261656888 P, 20120607 | | EP pub. no. and date |
EP 3533792 20190904 | | Effective date | | | Applicant/owner | Sloan Kettering Institute For Cancer Research, 1275 York Avenue
New York, NY 10065, US,
Aragon Pharmaceuticals, Inc., 10990 Wilshire Blvd. Suite 440
Los Angeles, CA 90024, US | | Applicant ref. no. | P76485DK01 | | Inventor | SMITH, Nicholas D., 1204 Beryl Street
San Diego, CA 92109, US,
DILHAS, Anna, Häsingerstr. 32
4055 Basel, CH,
OUERFELLI, Ouathek, 2077 Center Avenue, Apt. 3J
Fort Lee, NJ 07024, US,
HERBERT, Mark R., 4180 Amoroso Street
San Diego, CA 92111, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4184 (2006.01) , A61K 31/4439 (2006.01) , A61P 35/00 (2006.01) , C07D 401/04 (2006.01) | | Title | KRYSTALLINSKE FORMER AF EN ANDROGENRECEPTORMODULATOR | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2021 00041 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
